Geron Corp (GERN)
3.85
-0.01
(-0.26%)
USD |
NASDAQ |
May 08, 11:55
Geron Revenue (Quarterly): 0.304M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.304M |
December 31, 2023 | 0.023M |
September 30, 2023 | 0.164M |
June 30, 2023 | 0.029M |
March 31, 2023 | 0.021M |
December 31, 2022 | 0.103M |
September 30, 2022 | 0.297M |
June 30, 2022 | 0.073M |
March 31, 2022 | 0.123M |
December 31, 2021 | 1.04M |
September 30, 2021 | 0.109M |
June 30, 2021 | 0.107M |
March 31, 2021 | 0.137M |
December 31, 2020 | 0.05M |
September 30, 2020 | 0.108M |
June 30, 2020 | 0.043M |
March 31, 2020 | 0.052M |
December 31, 2019 | 0.171M |
September 30, 2019 | 0.131M |
June 30, 2019 | 0.101M |
March 31, 2019 | 0.057M |
December 31, 2018 | 0.375M |
September 30, 2018 | 0.165M |
June 30, 2018 | 0.208M |
March 31, 2018 | 0.318M |
Date | Value |
---|---|
December 31, 2017 | 0.191M |
September 30, 2017 | 0.163M |
June 30, 2017 | 0.174M |
March 31, 2017 | 0.537M |
December 31, 2016 | 0.094M |
September 30, 2016 | 5.108M |
June 30, 2016 | 0.211M |
March 31, 2016 | 0.749M |
December 31, 2015 | 0.22M |
September 30, 2015 | 35.36M |
June 30, 2015 | 0.251M |
March 31, 2015 | 0.537M |
December 31, 2014 | 0.178M |
September 30, 2014 | 0.16M |
June 30, 2014 | 0.341M |
March 31, 2014 | 0.474M |
December 31, 2013 | 0.225M |
September 30, 2013 | 0.181M |
June 30, 2013 | 0.112M |
March 31, 2013 | 0.765M |
December 31, 2012 | 0.689M |
September 30, 2012 | 0.636M |
June 30, 2012 | 0.13M |
March 31, 2012 | 1.254M |
December 31, 2011 | 0.251M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.021M
Minimum
Mar 2023
1.04M
Maximum
Dec 2021
0.1593M
Average
0.1075M
Median
Revenue (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | -- |
SELLAS Life Sciences Group Inc | -- |
Johnson & Johnson | 21.38B |
Pfizer Inc | 14.88B |
Immuneering Corp | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -55.39M |
Total Expenses (Quarterly) | 56.44M |
EPS Diluted (Quarterly) | -0.09 |
Enterprise Value | 1.929B |
Profit Margin (Quarterly) | -18.22K% |
Earnings Yield | -9.09% |
Normalized Earnings Yield | -9.091 |